Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis

doi:10.4330/wjc.v13.i3.55

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6986)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

317

WORD

259

HTML

2766

Figures (1-4)

381

Tables (1-1)

337

Sum=4060

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

420

Download

662

Sum=1082

Publishing Process of This Article

Item

Count

Browse

493

Download

1351

Sum=1844

Mar 26, 2021 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Cardiol. Mar 26, 2021; 13(3): 55-67
Published online Mar 26, 2021. doi: 10.4330/wjc.v13.i3.55

Full Size Figure Download Figure

Figure 4 Kaplan-Meier curves for combined, decompensation and death or heart transplantation endpoints for dichotomized interleukin-6 in N-terminal pro-brain natriuretic peptide and TroponinT stratified patients. Dashed: Parametric survival regression (loglogistic distribution), likelihood ratio P values. cTNT: cardiac TroponinT; IL6: Interleukin-6; NTProBNP: N-terminal pro-brain natriuretic peptide.

Citation: Hein SJ, Knoll M, Aus dem Siepen F, Furkel J, Schoenland S, Hegenbart U, Katus HA, Kristen AV, Konstandin M. Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis. World J Cardiol 2021; 13(3): 55-67
URL: https://www.wjgnet.com/1949-8462/full/v13/i3/55.htm
DOI: https://dx.doi.org/10.4330/wjc.v13.i3.55